Pulmonology

Dr. Rapoport of Mount Sinai discusses the clinical ingenuity fostered by the pandemic response, and what US healthcare must improve on in the near future.

Pathogenic mechanism between respiratory exposures and the development of AAV could be established in future research.

ALA chief medical officer Al Rizzo, MD, discusses plans to kickstart vaccine research and public health preventive measures.

David Rapoport, MD, explains his institutions development of emergency ventilators through a common sleep apnea device.

How the island nation has set an efficient model of care access and preparation that has allowed them to best manage COVID-19.

New research from the California Department of Public Health is shedding new light on the impact of wildfire smoke on out-of-hospital cardiac arrest.

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

The Proventil HFA generic approval comes at a time of greater inhaler therapy demand due to the respiratory burdens of the coronavirus.

COPD patients with unnoticed OSA are at a greater risk of hospital readmission and even all-cause mortality.

Al Rizzo, MD, of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.

New findings show asthmatic children in a highly-polluted region improved in small airway function when their bedroom air was filtered.

The American Thoracic Society has released a set of guidelines to help clinicians treating patients with COVID-19.

New pivotal phase 3 findings support an upcoming sBLA for the IL4 and IL13-targeting agent.

A Vancouver-based cohort shows association between increased infancy antibiotic use, gut microbiome manipulation, and asthma development by age 5.

Discussing an editorial in the Journal of Clinical Endocrinology & Metabolism with journal editor in chief Paul Stewart, MD.

A new perspective from federal and institutional experts explains the cause of disease severity and mortality in older, cardiovascular-risk patients.

How do e-cigarettes fit into the cardiovascular health paradigm? What more needs to be learned?

Breaking down the details of the E3 trial, and what more needs to be found in the follow-up.

New ACC findings show smokers given nicotine or non-nicotine e-cigarettes better in 12-week cessation than those just given counseling.

The Abbott-developed test platform is already used as a molecular point-of-care device for influenza A and B, Strep A, and respiratory syncytial virus.

Allergic rhinitis is the most frequent atopic coexisting disease in the LIBERTY ASTHMA VENTURE study.

New research is shedding light on national trends in outcomes and predictors of in-hospital mortality for patients undergoing surgical embolectomy for acute pulmonary embolism.

A pediatric version of the ASTHMAXcel mobile application will include games.

Digital tools can be leveraged to help treat more patients remotely.

Results of a study show the efficacy of an artificial intelligence chatbot for patients with asthma and pregnant women.